Cantargia Financials
| CANTA Stock | SEK 1.86 0.03 1.64% |
Cantargia |
Understanding current and past Cantargia Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of Cantargia's financial statements are interrelated, with each one affecting the others. For example, an increase in Cantargia's assets may result in an increase in income on the income statement.
Please note, the imprecision that can be found in Cantargia's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Cantargia AB. Check Cantargia's Beneish M Score to see the likelihood of Cantargia's management manipulating its earnings.
Cantargia Stock Summary
Cantargia competes with Bavarian Nordic, BioPorto, Zaptec AS, and CBrain AS. Cantargia AB , a biotechnology company, engages in the research and development of antibody-based treatments for life threatening diseases. Cantargia AB was founded in 2010 and is based in Lund, Sweden. Cantargia operates under Pharmaceuticals And Biosciences classification in Sweden and is traded on Stockholm Stock Exchange. It employs 19 people.| Instrument | Sweden Stock View All |
| Exchange | Stockholm Exchange |
| ISIN | SE0006371126 |
| Business Address | Ideon Gateway, Lund, |
| Sector | Healthcare |
| Industry | Biotechnology |
| Benchmark | Dow Jones Industrial |
| Website | www.cantargia.com |
| Phone | 46 4 62 75 62 60 |
| Currency | SEK - Swedish Kronor |
You should never invest in Cantargia without having analyzed its financial statements. Do not rely on someone else's analysis or guesses about the future performance of Cantargia Stock, because this is throwing your money away. Analyzing the key information contained in Cantargia's financial statements can give you an edge over other investors and help to ensure that your investments perform well for you.
Cantargia Key Financial Ratios
There are many critical financial ratios that Cantargia's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that Cantargia AB reports annually and quarterly.Cantargia Financial Ratios Relationships
Comparative valuation techniques use various fundamental indicators to help in determining Cantargia's current stock value. Our valuation model uses many indicators to compare Cantargia value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cantargia competition to find correlations between indicators driving Cantargia's intrinsic value. More Info.Cantargia AB is number one stock in return on equity category among its peers. It also is number one stock in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the Cantargia's earnings, one of the primary drivers of an investment's value.Cantargia AB Systematic Risk
Cantargia's systematic risk plays a vital role in portfolio allocation when considering its stock to be added to a well-diversified portfolio. Cantargia volatility which cannot be eliminated through diversification, requires returns over the risk-free rate. Over the long run, a well-diversified portfolio provides returns that match its exposure to systematic risk. In this case, investors face a trade-off between expected returns and systematic risk and, therefore, can only reduce a portfolio's exposure to systematic risk by sacrificing expected returns on the portfolio.
The output start index for this execution was thirty-six with a total number of output elements of twenty-five. The Beta measures systematic risk based on how returns on Cantargia AB correlated with the market. If Beta is less than 0 Cantargia generally moves in the opposite direction as compared to the market. If Cantargia Beta is about zero movement of price series is uncorrelated with the movement of the benchmark. if Beta is between zero and one Cantargia AB is generally moves in the same direction as, but less than the movement of the market. For Beta = 1 movement of Cantargia is generally in the same direction as the market. If Beta > 1 Cantargia moves generally in the same direction as, but more than the movement of the benchmark.
Cantargia November 22, 2024 Opportunity Range
Along with financial statement analysis, the daily predictive indicators of Cantargia help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of Cantargia AB. We use our internally-developed statistical techniques to arrive at the intrinsic value of Cantargia AB based on widely used predictive technical indicators. In general, we focus on analyzing Cantargia Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build Cantargia's daily price indicators and compare them against related drivers.
| Information Ratio | (0.18) | |||
| Maximum Drawdown | 48.23 | |||
| Value At Risk | (5.10) | |||
| Potential Upside | 6.11 |
Additional Tools for Cantargia Stock Analysis
When running Cantargia's price analysis, check to measure Cantargia's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Cantargia is operating at the current time. Most of Cantargia's value examination focuses on studying past and present price action to predict the probability of Cantargia's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Cantargia's price. Additionally, you may evaluate how the addition of Cantargia to your portfolios can decrease your overall portfolio volatility.